Email updates

Keep up to date with the latest news and content from BMC Palliative Care and BioMed Central.

Open Access Research article

Unbearability of suffering at the end of life: the development of a new measuring device, the SOS-V

Cees DM Ruijs1*, Bregje D Onwuteaka-Philipsen2, Gerrit van der Wal2 and Ad JFM Kerkhof3

Author Affiliations

1 Primary Care Center De Greev, Utrecht, the Netherlands

2 Department of Public and Occupational Health, EMGO Institute for Health and Care Research, Expertise Center for Palliative Care, VU University Medical Center, Amsterdam, the Netherlands

3 Department of Clinical Psychology, EMGO + Institute for Health and Care Research, VU University, Amsterdam, the Netherlands

For all author emails, please log on.

BMC Palliative Care 2009, 8:16  doi:10.1186/1472-684X-8-16


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1472-684X/8/16


Received:19 December 2008
Accepted:3 November 2009
Published:3 November 2009

© 2009 Ruijs et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Unbearable suffering is an important issue in end-of-life decisions. However, there has been no systematic, prospective, patient-oriented research which has focused on unbearable suffering, nor is there a suitable measurement instrument. This article describes the methodological development of a quantitative instrument to measure the nature and intensity of unbearable suffering, practical aspects of its use in end-stage cancer patients in general practice, and studies content validity and psychometric properties.

Methods

Recognizing the conceptual difference between unbearability of suffering and extent or intensity of suffering, we developed an instrument. The compilation of aspects considered to be of importance was based on a literature search. Psychometric properties were determined on results of the first interviews with 64 end-stage cancer patients that participated in a longitudinal study in the Netherlands.

Results

The instrument measures five domains: medical signs and symptoms, loss of function, personal aspects, aspects of environment, and nature and prognosis of the disease. Sixty nine aspects were investigated, and an overall score was asked. In 64 end-stage cancer patients the instrument was used in total 153 times with an average interview time varying from 20-40 minutes. Cronbachs alpha's of the subscales were in majority above 0.7. The sum scores of (sub)scales were correlated strongly to overall measures on suffering.

Conclusion

The SOS-V is an instrument for measuring the unbearability of suffering in end-stage cancer patients with good content validity and psychometric properties, which is feasible to be used in practice. This structured instrument makes it possible to identify and study unbearable suffering in a quantitative and patient-oriented way.

Background

Suffering of patients is inseparably connected with the work of the medical profession. Serious disease can result in serious suffering. At some point, it is possible that patients may consider their suffering unbearable. Some of these patients may request euthanasia.

In the Netherlands, the discussion about euthanasia started in the early seventies, and unbearable suffering was the central theme [1]. In 2002, an act regulating euthanasia, in which unbearable suffering is one of the pivotal criteria for due care [2].

Since 1991, studies have been carried out in the Netherlands to achieve transparency in the frequencies of end-of-life decisions [1-5]. Given an estimated number of 8.400 explicit requests for euthanasia each year, at a total of about 140.000 deaths, patients consider their suffering unbearable in the last phase of life in at least 6% of all deaths [6]. The estimated frequency of euthanasia and physician-assisted suicide was 1,8 percent of all deaths in 2005. The majority (87 percent) of these deaths took place in primary care, and cancer was the most frequent diagnosis (84 percent) [2,6]. However, all these studies were physician-oriented.

The transparency about the nature and frequency of end-of-life decisions in medical practice in the Netherlands is not paralleled by a clear understanding of what patients consider unbearable suffering, since in nearly four decades the nature of unbearable suffering has not yet been studied through patient-oriented research [7]. Important reasons for studying unbearable suffering this way are the understanding of unbearable suffering, analysis of end-of-life decisions, and assessing and directing care needed.

We planned a longitudinal, prospective, quantitative patient-oriented study of the nature and intensity of unbearable suffering in end-stage cancer patients in primary care. In 2001, in preparation of our study, we performed a Medline literature search for patient-oriented studies focusing on unbearable suffering. Key words we used in different combinations were: unbearable suffering, suffering, quality of life, measure, cancer patients, palliative, general practice, primary care, euthanasia. We also studied a sample of convenience from the Dutch medical literature concerning unbearable suffering and end-of-life decisions. A compilation of over 200 articles related to the subject was studied. No patient-oriented research investigating unbearable suffering was found. Above that, no measurement instrument for unbearable suffering was found. At first glance, a quality-of-life instrument would appear an option. However years of clinical, and research experience within the research group showed a recurring phenomenon: in patients in whom no difference in quality of life was observed or expressed some would consider their suffering unbearable and ask for euthanasia, and others would not. In other words, the extent to which burdensome signs or symptoms are present does not necessarily parallel the experience of unbearability. This is what distinguishes unbearable suffering from health-related quality of life which is usually measured by assessing the extent to which signs or symptoms are present.

We decided to develop an instrument to measure the unbearability of suffering at the end of life. This article describes its development, giving insight in the content validity of the measurement instrument. Furthermore, we describe our experience with the practical use of the instrument in end-stage cancer patients and the psychometric properties of the instrument.

Methods

For the systematic development of the instrument we defined unbearable suffering, decided whether or not non-disease-related aspects should be included, defined an integral framework of the main domains of suffering, implemented specific aspects of suffering in the framework, and developed a method of questioning patients about (un)bearability. The research group provided expertise in medicine (especially general practice and public health), psychology and health sciences.

Definition

We defined unbearable suffering as a subjective experience of suffering that is so serious and uncontrollable that it overwhelms ones bearing capacity. This experience is not a steady state, but a state that fluctuates in intensity. This corresponds with the experience of physicians, who observe how a patient can feel unwell one day, and then better on another day. This can for instance depend on activities during the day, social contacts or treatment, or can have no apparent explanation.

Framework of suffering and process of selection of aspects

The experience of suffering is a multidimensional entity with physical, psychological, social, existential and spiritual dimensions [8-10]. Thus, in the medical professional field, suffering will comprise disease-related and non-disease-related aspects and an integral instrument should account for both, resulting in a comprehensive measurement of suffering. A second reason to include non-disease-related aspects is the relationship between unbearable suffering and end-of-life decisions, which in it's essence are existential decisions [11]. In the literature we found two frameworks for the experience of suffering [12,13] with focus upon the domains of suffering as encountered in medical practice. We selected a framework with five domains: (I) medical signs and symptoms, (II) loss of function, (III) personal aspects, (IV) aspects of environment, (V) nature and prognosis of the disease [12]. Therefore, we named the instrument the State Of Suffering-Five (for five domains), in short: SOS-V 9 Additional file 1).

Additional file 1. SOS-V. the complete SOS-V measuring instrument.

Format: PDF Size: 47KB Download file

This file can be viewed with: Adobe Acrobat ReaderOpen Data

A compilation was made of aspects of suffering that were considered to be of importance in the studied literature, when focusing on end-stage cancer patients [1,4,7-9,11,14-33]. In a process of reflection and interaction the research group selected aspects and divided them over the five specific domains. Since this study originated in medical practice, emphasis was laid on the domain of medical signs and symptoms.

The items listed can predominantly be considered as causal indicators, which may cause unbearable suffering if present, while it is not necessary that people who suffer unbearably score high on these items. Therefore, in developing a valid instrument an important aim is that the list of items is comprehensive. This as opposed to selecting as few items as possible to validly measure a concept, as is done in items that can be considered effect indicators (e.g. depression screening scales) [34,35]. Focussing on comprehensiveness, we selected 69 aspects, while working towards an interview time of 30-45 minutes. Since a study among terminally ill cancer patients showed that for a majority of patients an interview with median duration of 83 minutes was acceptable [36], this could even leave time to address other topics in the interview.

Measuring unbearable suffering

The next step was to formulate a question with which to measure unbearable suffering per aspect. Quality of life studies generally measure the extent or intensity of a symptom or complaint. This is important information, but as such it does not determine the unbearability of the suffering. A high score for an aspect of suffering might be unbearable for one person, but bearable for another person. Therefore, we concluded that two questions would be necessary: first asking about the intensity or extent to which an aspect was present, followed by a question on how unbearable it was.

Eligibility criteria and other interview- and study information

Because of the target population of end-stage cancer patients, the mode of gathering information was chosen to be an interview. The patients were handed a card with the answering options to help choosing their answer. For this study, with the purpose of recording change in the last phase of life, the recall period of the instrument was 'the last two days'.

The interview was tested four times in patients with end-stage cancer who only had a few months to live, after which a few questions were reformulated. The resulting instrument was used in the actual study which was carried out in primary care in Utrecht, one of the four largest cities in the Netherlands. The study was approved by the ethical committee of VU University Medical Center. Patients were eligible if they had incurable cancer, an estimated life-expectancy of six months or less, were competent, had adequate command of the Dutch language, were expected to stay mostly at home, and had a general practitioner as the primary responsible physician. Sixty four patients were followed from inclusion until they deceased.

Forty five general practitioners invited eligible patients to participate in the study. The interviews took place in the patients home every two months, or sooner if the condition of the patient deteriorated (information provided by the general practitioner). In this paper, the data on the first interviews were used. In the first interview we used the SOS-V and several other instruments, among which the EORTC QLQ C30 [14], a health-related quality of life measurement for cancer patients. If, during the interview, the interviewer sensed that the general condition of the patient was too poor, the interview was cut short. Then preference was given to the SOS-V. The interview time was estimated approximately. At the end, the patient was asked how he or she had experienced the interview., This was not rated as a score, but was asked more openly, in order to end the interview on a more informal note.

Translation of the instrument

The original language of the study was Dutch. Therefore, the validation of the instrument concerns the Dutch version. For the purpose of international publications, a back and forward translation into English took place. The instrument was translated to English by a native speaker, after which it was translated back into Dutch by a researcher not involved in this study. The few differences found were discussed between the two translators and one of the researchers (BOP) to decide on the appropriate English translation.

Analysis of psychometric properties

Internal consistency was analysed with cronbachs alpha's for the 5 domains and for the total of aspects. This was done separately for the questions on the presence of the aspect and for the questions on the unbearabilty of these aspects. To examine the extent to which the conceptual difference between (a) the presence of aspects, and (b) the extent to which they lead to unbearable suffering actually exists in practice, scatter plots of presence (a) versus the sum cores of unbearability (b) were made for the sums cores per domain. Furthermore, the correlations between sum scores of the 5 domains and overall measures on extent of, unbearability of and hopelessness of suffering were calculated. Finally, the correlation between the sum scores of the sub domains and sum scores of the total SOS-V, and the sum score of the EORTC QLQ C-30 was calculated.

Results

The SOS-V

Table 1 shows the SOS-V, with the five domains of experience of suffering which we distinguished, the division of 69 aspects of suffering over these domains, and the additional questions. The domain "medical signs and symptoms" consists of most aspects: 37 aspects ordered following organ and functional systems.

Table 1. Domains and aspects of the SOS-V

Table 2 shows the two questions we used per aspect to measure the presence of the aspect, and the extent to which it was unbearable. Since unbearable suffering was defined as a condition that is present to a certain degree, it was possible to measure it in a range of scores. We constructed a five point scale with a parallel description for scoring. To keep the scoring simple we chose a uniform scale for both questions. This had consequences for the way in which the questions were formulated. The second question was not asked if the first score was 1. If a patient scored 4 or 5 for unbearability on an aspect, then in an open-ended question the patient was asked to specify the experience. To ensure comprehensiveness, after posing questions on the 69 aspects, the patient was asked to name any aspects of suffering that had not been mentioned. After that, there were three questions on the overall severity, unbearability, and hopelessness of the respondents' suffering. To analyse dimensions which determine the capacity to bear suffering the interview was ended with four open questions addressing the nature of one's capacity to bear suffering, the role of spirituality, the influence of previous experience of suffering caused by disease and unexpected positive consequences of one's disease. The complete instrument can be seen in the appendix.

Table 2. Questions about the unbearable suffering

Practical use of the instrument

Our data collection started May 2003, and the inclusion period lasted until April 2006. In the study group of 64 patients 175 interviews were held, 130 (76%) of which were complete. Four times the interview was impossible, because of the poor condition of the patient. The remaining 45 interviews were incomplete in the sense that not all the different sub-instruments had been administered; in 22 of these interviews the SOS-V was not completed. Thus the SOS-V was completed in 153 interviews (85%). Two interviews were interrupted because the patient was too tired; on these occasions the interview was completed a few days later. Completing the interview took approximately 60-75 minutes. In general, the completion of the SOS-V took 20-40 minutes. When it took longer, this was generally because the patients appreciated the opportunity to talk about things that they felt were important. They were given enough time to do so. As the experience of the interviewers increased, the interview time tended to decrease. In general, the interviews were experienced positively by the patients.

Eleven patients (17%) named 20 aspects in response to the question to name aspects of their suffering that were not among the 69 aspects. The analysis showed that seven aspects, that were all mentioned once, were really additional: cramps in the extremities, oedema of feet, tingling of feet after chemotherapy, poly urea, cold extremities, irritation and intolerance due to loss of naivety, and the legal bureaucracy involved in obtaining income when sick. The other thirteen aspects mentioned, were attributable to existing aspects of the SOS-V.

Psychometric properties

Table 3 shows the average scores on presence and unbearability of the individual aspects for the first interviews. Most frequently the averages are between 1 and 2. This is related to the frequency an aspect is not present (and thus also not unbearable). Of the aspects 47 of 69 aspects is present in less than 50% of respondents. Table 4 shows that the cronbach's alpha for the subscales varied between 0.57 and 0.89, and that most subscales had a cronbach's alpha of over 0.7. This level can be seen as a level of sufficient internal consistency[37]. The internal consistency of the total SOS-V was substantial with cronbachs alpaha's of 0.90 for presence of aspects and 0.93 for unbearability of aspects. Furthermore, for all (sub)scales the cronbach's alpha's were higher for the questions on unbearability of aspects than for the questions on presence of aspects.

Table 3. Average scores for presence (a) and unbearability (b) of the individual SOS-V aspect in the first interviews (n = 64)*

Table 4. Internal consistency of the SOS-V subscale and total used at the first interviews with patients in general practice with incurable cancer with a life-expectancy of 6 months or less (cronbach's α, n = 64)*

Figure 1 shows that for all (sub)scales the answers for presence were not identical to the answers for unbearability. However, they were strongly correlated, with correlations from 0,77 (for domain II) to 0.91 (for domain IV). For all (sub)scales, in the majority of cases the sum score for presence was higher than the sum score for unbearability.

thumbnailFigure 1. Scatter plots of the sum scores on 'aspect present?' (x-axis) versus 'aspect unbearable?' (y-axis) for sub scales and total of the SOS-V.

Table 5 shows the correlations of sum scores of (sub)scales with the three overall questions on suffering. All but two correlations (between aspects of social environment and overall unbearability of suffering, and between nature and prognosis of disease and overall hopelessness of suffering) between subscales and overall measures were significant. In general, the (sub) scales' questions on extent of suffering were somewhat higher correlated to the overall extent of suffering than the overall unbearability of suffering; e.g. 0.72 versus 0.66 for the total scale. Similarly, the (sub) scales' questions on unbearability of suffering were somewhat higher correlated with the overall unbearability than with the overall extent of suffering. Domain II and IV were less correlated to the overall measures of suffering, compared to the other domains and the total SOS-V. The correlations of the (sub)scales with overall measure of hopelessness of suffering were generally somewhat lower than with the other two overall measures. An exception was domain IV for which the correlations were highest with overall hopelessness of suffering.

Table 5. Correlations between sum scores of SOS-V (sub)scales with patient with patient's general feeling of suffering and sum score of the QLQ C-30; first interviews with patients in general practice with incurable cancer with a life-expectancy of 6 months or less (Spearman R, n = 64)*

While the correlations between the total SOS-V scores and the EORTC QLQ C30 were high (0.66 for aspect present and 0.58 for aspect unbearable), the correlations differed substantially per sub domain of the SOS-V: they were relatively high for the first and second domain and lower for the other domains, especially for domain IV. (Table 5)

Discussion

Unbearable suffering may be feared or experienced by patients with an incurable disease, but it has not yet been the focus of patient-oriented studies. We carried out a prospective, patient-oriented study to investigate the nature and intensity of unbearable suffering, for which it was necessary to develop a measurement instrument. Based on a systematic study of the literature, we developed a quantitative measurement instrument. We hypothesize that unbearable suffering occurs when the suffering exceeds the bearing capacity of the individual. For some persons this may occur at the level of individual dimensions. For other persons unbearable suffering may occur when the sum of suffering of diverse dimensions exceeds the bearing capacity. The approach of a framework of suffering based on diverse domains may define a complementary pathway of palliative care, in which relieving measures of care in one domain may result in increased bearing capacity 'available' to bear suffering in another domain. This mechanism may also account for aspects of suffering within one domain.

Content validity refers to the extent to which the concepts of interest are comprehensively represented by the items of an instrument. Important in judging the content validity is whether the measurement aim, target population, and underlying concepts are taken into consideration appropriately in developing the instrument [37]. The above shows that this has been done in developing the SOS-V. Furthermore, in selecting items for the SOS-V we used literature, expert opinions and the target population. Although the pilot study was limited to a few patients of the target population, the use of the instrument in the study showed that most patients did not add extra items. This suggests that among the target population the item list is generally comprehensive. This opportunity to add relevant items is important, as suffering is a subjective experience. It is especially important when the instrument is used in other populations than the population for which it was developed. For instance, in the Netherlands, virtually all people have health insurance. Therefore, the financial impact of a life-limiting illness might be a more important aspect in countries with lower coverage of health insurance. Similarly, it is possible that in a secularized country like the Netherlands spiritual issues are different than in other countries.

The comparison with the overall scores on suffering suggests that the SOS-V actually measures suffering. The added value of the use of the SOS-V compared to overall scores is that it gives insight in the sources of suffering. The internal consistency of the instrument is acceptable, except may be for domain IV and V. However, it is debatable how necessary internal consistency is in an instrument of which the items are mainly causal indicators [35,36]. A limitation of the study is that it was not feasible to study test-retest reliability. In studies in patients in the last phase of life the retest should take place within less than a week of the first interview [37], and we assessed that this would limit the willingness to participate in the prospective part of the study with interviews every 2 months (a period too long for test-retest).

In the development of the instrument, the conceptual difference between the presence of an aspect and it's unbearability was an important starting point. The results show that there is indeed a difference between presence of aspects and unbearability. However, the difference is not as large as we expected. In interpreting the correlations between presence and unbearability, it should be understood that if an aspect was not present, by definition unbearability was also not present. This contributed to the high correlations, especially when many aspects were not present. In light of the conceptual difference between presence and unbearability, and the differences found between these (however small), we think it is important that the SOS-V consists of both questions. However, it could be debated that depending on the purpose of use of the SOS-V, and the need for briefness in the data collection one could opt for only one of the questions (either on presence or on unbearability).

The relatively high correlations of the SOS-V scores with the total score on the EORTC QLQ C30 are an indication for criterion validity of the instrument. At the same time, the fact that this high correlation is especially to be contributed to the first two domains -- 'medical signs and symptoms' and 'loss of function' -- confirms the difference between health-related quality of life and suffering. The SOS-V gives more information on the less medical, more psychosocial aspects of suffering. That this is relevant is indicated by the significant correlations between the sub domains III to V and the overall measures of suffering.

In our study of 64 end-stage cancer patients, 175 interviews were carried out. The SOS-V was completed 153 times, which demonstrates the feasibility of the instrument in practice. The interview time for the SOS-V varied between 20-40 minutes; the duration of the interviews was influenced by open-ended questions asking for more specific information if the scores were high, and also by the way in which the patients appreciated the opportunity to talk about their disease and its impact on their lives. For some patients the interview time was too long. After completion of other parts of the interview 22 times patients were too tired for the SOS-V, and four times the interview was impossible because of the poor condition of the patient.

Conclusion

We conclude that with the development of the SOS-V we developed an instrument for measuring the unbearability of suffering in end-stage cancer patients with a good content validity and psychometric properties, which is feasible to be used in practice. This quantitative instrument to measure the unbearability of suffering offers an important step to better understanding the phenomenon of unbearable suffering through gaining information directly from patients. It also will make it possible to study whether palliative care interventions influence the experienced unbearability of suffering. Of course, when used in other countries, in other languages, or in other patient groups, attention for validation of the instrument is again important.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

All authors contributed to the design of the study and the development of the SOS-V. BOP is responsible for acquisition of funding. KR participated in data collection and drafted the manuscript. AK, GvdW, BOP have been in revising the manuscript for important intellectual content. All authors read and approved of the final manuscript.

Acknowledgements

We would like to thank Janneke Goedhart for organizing the data collection and interviewing the patients. This study was funded by an Aspasia fund from the Netherlands Organisation for Scientific Research (NWO).

References

  1. Wal G, Maas PJ, Bosma J, et al.: Evaluation of the notification procedure for physician-assisted death in the Netherlands.

    N Engl J Med 1996, 335:1706-11. PubMed Abstract | Publisher Full Text OpenURL

  2. Heide A, Onwuteaka-Philipsen BD, Rurup ML, et al.: End-of-life practices in the Netherlands under the euthanasia act.

    N Engl J Med 2007, 356:1957-65. PubMed Abstract | Publisher Full Text OpenURL

  3. Maas PJ, Wal GJ, Haverkate I, et al.: Euthanasia, physician-assisted suicide, and other medical practices involving the end of life in the Netherlands, 1990-1995.

    N Engl J Med 1996, 335:1699-705. PubMed Abstract | Publisher Full Text OpenURL

  4. Wal G, van Eijk JThM, Leenen HJJ, Spreeuwenberg C: Euthanasia and assisted suicide. II. Do Dutch family doctors act prudently?

    Fam Practice 1992, 9:135-140. Publisher Full Text OpenURL

  5. Onwuteaka-Philipsen BD, Heide A, Koper D, et al.: Euthanasia and other end-of-life decisions in the Netherlands in 1995, and 2001.

    Lancet 1990, 362:395-9. Publisher Full Text OpenURL

  6. Onwuteaka-Philipsen BD, Gevers JKM, Heide A, et al.: Evaluation of the Dutch Euthanasia Act.

    Print Partners Ipskamp, Enschede 2007, 102-103.

    In Dutch

    OpenURL

  7. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM: Who should measure quality of life, the doctor or the patient?

    Br J Cancer 1988, 57:109-112. PubMed Abstract | PubMed Central Full Text OpenURL

  8. Axelsson B, Sjödén PO: Quality of life of cancer patients and their spouses in palliative home care.

    Palliat Med 1998, 12:29-39. PubMed Abstract | Publisher Full Text OpenURL

  9. Donovan K, Sanson-Fisher RW, Redman S: Measuring quality of life in cancer patients.

    J Clin Oncol 1989, 7:959-68. PubMed Abstract | Publisher Full Text OpenURL

  10. Osaba D: Lessons learned from measuring health-related quality of life in oncology.

    J Clin Oncol 1994, 12:608-16. PubMed Abstract | Publisher Full Text OpenURL

  11. Faber-Langendoen K: Death by request. Assisted suicide and the oncologist.

    Cancer 1998, 82:35-41. PubMed Abstract | Publisher Full Text OpenURL

  12. Beijk MM: Unbearable suffering. What is it, what is the cause and who determines its presence?

    Med Contact 1998, 53:825-7.

    In Dutch

    OpenURL

  13. Emanuel EJ, Emanuel LL: The promise of a good death.

    Lancet 1998, 351(suppl II):21-9. OpenURL

  14. Aaronson NK, Ahmedzai S, Bergman B, et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology.

    J Natl Cancer Inst 1993, 85:365-376. PubMed Abstract | Publisher Full Text OpenURL

  15. Bruera E, Kuehn N, Miller J, Selmser P, Macmillan K: The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients.

    J Palliat Care 1991, 7(2):6-9. PubMed Abstract OpenURL

  16. Haes JCJM de, van Knippenberg FCE, Neijt JP: Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist.

    Br J Cancer 1990, 62:1034-1038. PubMed Abstract | PubMed Central Full Text OpenURL

  17. Zigmund AS, Snaith RP: The hospital anxiety and depression scale.

    Acta Psychiatrica Scand 1983, 67:361-370. Publisher Full Text OpenURL

  18. Griffiths J, Bood A, Weyers H: Euthanasia & Law in the Netherlands. Amsterdam: University Press; 1998.

  19. Legemate J, Dillmann RJM: Physician act of ending life: between norm and practice.

    Bohn Stafleu van Loghum First edition. 1998.

    In Dutch

    OpenURL

  20. Macleod J: Clinical Examination. Sixth Edition. Churchill Livingstone; 1983.

  21. NVVE (Right-to-die-NL): My life! My death? Reflections upon accountable self-determination. Amsterdam. Thesis Publishers; 1998.

    In Dutch

  22. Wal G, Maas PJ: Euthanasia and other medical decisions concerning the end of life. SDU Uitgevers, Den Haag; 1996.

    In Dutch

  23. Wal G: Euthanasia and physician assisted suicide by general practitioners.

    WYT Uitgeefgroep, Rotterdam 1992.

    In Dutch

    OpenURL

  24. Gotay CC: The experience of cancer during early and advanced stages: the views of patients and their mates.

    Soc Sci Med 1984, 18:605-613. PubMed Abstract | Publisher Full Text OpenURL

  25. Gill TM, Feinstein AR: A critical appraisal of the quality of quality-of-life measurements.

    JAMA 1994, 272:619-626. PubMed Abstract | Publisher Full Text OpenURL

  26. Higginson I, Wade A, McCarthy M: Palliative care: views of patients and their families.

    BMJ 1990, 30:277-81. Publisher Full Text OpenURL

  27. Houts PS, Yasko JM, Harvey HA, et al.: Unmet needs of persons with cancer in Pennsylvania during the period of terminal care.

    Cancer 1988, 62:627-634. PubMed Abstract | Publisher Full Text OpenURL

  28. Schadé E, Gersons-Wolfenberger DChM, Schornagel JH: Developments in the care for patients with cancer.

    Ned Tijdschr Geneeskd 1992, 136:141-145.

    In Dutch

    PubMed Abstract OpenURL

  29. Smelt WLH: The one-sided discussion about euthanasia. Selective attention for regulation bypassing the process of diagnostics and formulating indications.

    Med Contact 1997, 52:589-590.

    In Dutch

    OpenURL

  30. Spiegel D, Sands S, Koopman C: Pain and depression in patients with cancer.

    Cancer 1994, 74:2570-8. PubMed Abstract | Publisher Full Text OpenURL

  31. Sullivan MD, Youngner SJ: Depression, competence, and the right to refuse lifesaving medical treatment.

    Am J Psychiatry 1994, 151:971-978. PubMed Abstract | Publisher Full Text OpenURL

  32. Testa MA, Simonson DC: Assessment of quality-of-life outcomes.

    N Engl J Med 1996, 334:835-40. PubMed Abstract | Publisher Full Text OpenURL

  33. Wal G, Dillmann RJM: Euthanasia in the Netherlands.

    BMJ 1994, 308:1346-9. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  34. Fayers PM, Hand DJ: Factor analysis, causal indicators and quality of life.

    Quality of Life Research 1997, 6:139-150. PubMed Abstract | Publisher Full Text OpenURL

  35. Fayers PM, Hand DJ, Bjordal K, Groenvold M: Causal indicators in quality of life research.

    Quality of life research 1997, 6:393-406. PubMed Abstract | Publisher Full Text OpenURL

  36. Barnett M: Interviewing terminally ill people: is it fair to take their time?

    Pall Med 2001, 15:157-158. Publisher Full Text OpenURL

  37. Terwee CB, Bot SD, de Boer MR, et al.: Quality criteria were proposed for measurement properties of health status questionnaires.

    J Clin Epidemiol 2007, 60:34-42. PubMed Abstract | Publisher Full Text OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1472-684X/8/16/prepub